Compounds > 20-hydroxy-5,8,11,14-eicosatetraenoic acid
Page last updated: 2024-09-03

20-hydroxy-5,8,11,14-eicosatetraenoic acid and warfarin

20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with warfarin in 1 studies

Compound Research Comparison

Studies
(20-hydroxy-5,8,11,14-eicosatetraenoic acid)		Trials
(20-hydroxy-5,8,11,14-eicosatetraenoic acid)		Recent Studies (post-2010)
(20-hydroxy-5,8,11,14-eicosatetraenoic acid)		Studies
(warfarin)		Trials
(warfarin)		Recent Studies (post-2010) (warfarin)
6401323336,5732,14314,728

Protein Interaction Comparison

ProteinTaxonomy20-hydroxy-5,8,11,14-eicosatetraenoic acid (IC50)warfarin (IC50)
Vitamin K epoxide reductase complex subunit 1 Homo sapiens (human)0.0088

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altman, RB; Alvarellos, ML; Daneshjou, R; Klein, TE; Sangkuhl, K; Whirl-Carrillo, M1

Reviews

1 review(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and warfarin

ArticleYear
PharmGKB summary: very important pharmacogene information for CYP4F2.
    Pharmacogenetics and genomics, 2015, Volume: 25, Issue:1

    Topics: Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Pharmacogenetics; Warfarin

2015